Overview

Update
Total Equity Funding
$69.44M in 5 Rounds from 10 Investors
Most Recent Funding
$30M Series B on October 2, 2014
Headquarters:
Cambridge, Massachusetts
Description:
Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.
Founders:
Categories:
Therapeutics, Biotechnology, Clinical Trials
Website:
http://www.visterrainc.com

Company Details

Update

Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Funding Rounds (6) - $75.44M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2014$30M / Series B8
Dec, 2013$8.1M / Series A5
Nov, 2012$26.1M / Series A5
Aug, 2010$6M / Debt Financing3
Dec, 2009$3.2M / Venture0
Feb, 2008$2.04M / Seed1

Current Team (10)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • HQ

    One Kendall Square,

    Suite B3301

    Cambridge, Massachusetts 02139

    United States

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos